Tag: hormoneReceptorPositive

Hormone receptor positive (ER+/PR+): Breast cancer that is estrogen receptor positive (ER+) and progesterone receptor positive (PR+). Some researchers classify mixed hormone receptor disease such as ER+/PR- as hormone receptor positive.

Articles

News

04/01/17
Saffron carotenoid crocin inhibits breast cancer cell division
02/26/17
Ursolic acid causes death of various types of breast cancer cells
10/09/16
Melatonin reduces the viability of both ER+ and ER- breast cancer stem cells
06/27/16
Gamma-tocotrienol form of vitamin E suppresses breast cancer cell metastasis
05/22/16
Plant-based omega-3 fatty acid ALA reduces ER+/PR+ breast cancer growth
05/16/16
Fruit consumption during adolescence linked to lower breast cancer risk, especially ER-/PR-
04/08/16
Genistein could reduce treatment effects of Adriamycin chemotherapy in ER+/PR+ disease
03/06/16
Luteolin inhibits proliferation of both hormone receptor positive and triple negative breast cancer cells
02/21/16
HDL cholesterol from breast cancer patients with type 2 diabetes can promote metastasis
02/08/16
Resveratrol enhances the treatment effects of Adriamycin in ER+/PR+ and triple negative cells
11/10/15
Black cumin increases the effectiveness of many types of breast cancer treatment
10/18/15
Late recurrence of ER+ breast cancer is more likely for women with large tumors and positive lymph nodes
10/06/15
Pink Lady apple peel inhibits ER+/PR+ breast cancer growth in a dose-dependent manner
05/17/15
Artichoke compound silibinin promotes ER+/PR+ breast cancer cell death
03/29/15
Kaempferol reduces ER+/PR+ breast cancer proliferation by inhibiting glucose uptake
02/28/15
Pomegranate and berry compound ellagic acid inhibits ER+/PR+ breast cancer growth
02/22/15
Blueberry and ginger compounds increase effects of Taxol on ER+/PR+ breast cancer stem cells
01/19/15
Melatonin heightens effects of radiation treatment in ER+/PR+ breast cancer cells
10/05/14
Walnut compounds impair breast cancer energy supply and induce cell death
06/29/14
Arugula compound erucin inhibits proliferation of ER+ breast cancer cells
05/26/14
Breast cancer surgery should not be omitted in relatively healthy ER+ older women
04/26/14
Kaempferol reduces ER+/PR+ breast cancer growth and protects against triclosan exposure
12/15/13
Even low levels of phthalate exposure can increase breast cancer cell proliferation
11/30/13
Vitamin C can reduce the effectiveness of tamoxifen treatment
11/25/13
Whole blueberry powder reduces breast cancer formation and growth in animal model
11/16/13
Fish oil reduces lung metastases in mouse model of breast cancer
10/28/13
Salad and wine dietary pattern increases breast cancer risk whereas plant-based diet reduces it
09/16/13
High blood sugar and obesity both reduce ER+/PR+ breast cancer survival
08/18/13
Cadmium reduces effectiveness of 5-FU chemotherapy in ER+/PR+ breast cancer cells
07/27/13
Aluminum increases migration and invasion of ER+ breast cancer cells
06/16/13
Resveratrol enhances the effectiveness of Adriamycin in ER+/PR+ breast cancer cells
05/21/13
Reduction in breast density from tamoxifen treatment is linked to favorable prognosis
05/07/13
Luteolin can increase responsiveness to treatment in tamoxifen-resistant breast cancer cells
03/29/13
Blueberry compound inhibits breast cancer stem cell generation and activities
02/22/13
Coffee may reduce risk of recurrence in tamoxifen-treated breast cancer patients
02/10/13
Parabens at levels found in breast tissue can increase proliferation of breast cancer cells
12/21/12
Garlic compound induces programmed cell death in ER+/PR+ breast cancer cells
12/09/12
Continuing tamoxifen treatment for 10 years helps prevent late recurrence
10/17/12
Pomegranate juice inhibits metastatic processes in breast cancer cells
10/14/12
Fatty fish compound DHA increases Adriamycin efficacy in triple negative breast cancer cells
08/20/12
High circulating vitamin B6 linked to lower risk of ER+/PR+ breast cancer
08/12/12
Lymph node negative breast cancer has less favorable prognosis for ER-/PR- disease
07/31/12
I3C in cruciferous vegetables inhibits proliferation of ER+ breast cancer cells
07/15/12
Reduction in breast density shows endocrine treatment is working
06/27/12
Lycopene inhibits ER+/PR+ breast cancer cell proliferation
06/20/12
Large breast size linked to reduced survival for ER+ breast cancer
05/15/12
Blueberries and raspberries both reduce mammary tumor development
05/13/12
A story of long-term stage IV HER2+ breast cancer survival
05/06/12
What are the characteristics of breast cancer with low risk of recurrence?
04/25/12
Bilateral mastectomy can improve ER-/PR- breast cancer survival in some cases
04/12/12
Five-year prognosis by breast cancer subtype
03/22/12
Animal model of ER+/PR+ breast cancer shows that estrogen fuels recurrence
03/12/12
Study finds olive oil does not reduce breast cancer risk, contradicting previous reports
02/22/12
Selenium increases effectiveness of Taxol chemotherapy for triple negative breast cancer
02/20/12
Cruciferous vegetable consumption linked to reduced risk of cancer
01/17/12
Apigenin increases effectiveness of Taxol chemotherapy
01/16/12
Lack of melatonin increases risk of breast cancer
12/07/11
Modern chemotherapy reduces breast cancer death by about a third compared to no chemotherapy
12/06/11
Red clover compound biochanin A reduces potency of tamoxifen in rats
12/02/11
Knowing the receptor status of metastases improves treatment decisions
11/17/11
Brown seaweed compound fucoidan induces breast cancer cell death
10/31/11
High circulating estrogen and androgen increase risk of postmenopausal breast cancer
10/25/11
Milk increases proliferation of estrogen-sensitive breast cancer cells
10/22/11
Young breast cancer patients require aggressive treatment
10/20/11
Age and breast cancer subtype influence prognosis after lumpectomy
10/13/11
Coexisting DCIS independently predicts lower tumor aggressiveness in luminal breast cancer
09/27/11
Hormone receptor status changes during progression in over one-third of breast cancer cases
09/11/11
Calycosin in astragalus root (huang qi) promotes ER+ breast cancer cell proliferation
09/09/11
Diet high in fruits and vegetables is associated with a lower risk of ER- breast cancer
09/07/11
Strongly estrogen positive lobular breast cancer responds well to neoadjuvant Femara
08/24/11
Morphine promotes ER+/PR+ and ER-/PR- breast cancer cell migration
08/20/11
Coffee is not linked to ER+/PR+ or ER-/PR- breast cancer risk among postmenopausal women
08/17/11
Genistein stimulates aromatase activity and ER+ breast cancer cell growth
08/16/11
Pomegranate fruit may help prevent estrogen sensitive breast cancer
08/01/11
Breast cancer subtype influences prognosis after neoadjuvant chemotherapy
07/31/11
High dose vitamin D reduces musculoskeletal symptoms in women taking Arimidex
07/17/11
Increasingly severe side effects of aromatase inhibitors may make tamoxifen first the best strategy
06/27/11
Chemotherapy might have different effectiveness in lobular compared to ductal breast cancer
06/19/11
Metformin reduces risk of ER+/PR+ breast cancer in postmenopausal women
06/18/11
Plasticizer bisphenol A promotes mammary cancer in mice
06/15/11
White button mushroom extract has mild influence on aromatase activity
06/09/11
Patients with ER-/PR+ breast cancer benefit from endocrine therapy
06/03/11
Likelihood of late recurrence for hormone receptor positive breast cancer is hard to predict
05/20/11
Caffeic acid phenethyl ester (CAPE), a component of propolis, inhibits breast cancer growth
05/17/11
Estrogen and insulin-like growth factor-I promote breast cancer together and independently
05/10/11
Apigenin may prevent breast cancer that develops in response to progestin
05/09/11
Curcumin and DHA act synergistically in hormone receptor negative HER2+ breast cancer
05/05/11
Measles virus may be associated with breast cancer
04/24/11
Early detection with screening mammograms leads to improved breast cancer survival
04/13/11
ER+/PR- or ER-/PR+ tumors more likely to recur locally than ER+/PR+ breast cancer
03/23/11
Obesity increases inflammation and estrogen production in breast tissue
03/22/11
Taking tamoxifen for all 5 years reduces long-term risk of breast cancer recurrence
03/12/11
Blood of mice implanted with beef growth promoter zeranol increases breast cell proliferation
03/02/11
Risk of second primary breast cancer highest in hormone receptor negative survivors
03/01/11
Aromatase inhibitor only or after tamoxifen are both effective treatments
02/20/11
Effectiveness of MRI in monitoring effectiveness of chemotherapy depends on subtype
02/14/11
Removing ovaries during second half of menstrual cycle improves survival
01/27/11
Obesity is linked to inferior prognosis for hormone receptor positive breast cancer
01/24/11
Breast cancer prognosis does not depend on whether the tumor is ductal or lobular
01/23/11
Non-digestible carbohydrates reduce growth of estrogen-dependent breast cancer in mice
01/03/11
Removing ovaries before age 45 reduces risk of breast cancer
12/29/10
Old women tend to have less aggressive breast cancer and are given less treatment
12/24/10
Male breast cancer patients are less likely to survive than female patients
12/18/10
Diets rich in fruit and salads protect against hormone receptor negative breast cancer
11/30/10
Small triple negative tumors have worse prognosis than small ER+/PR+ tumors
11/21/10
Black rice compound induces breast cancer cell death and suppresses angiogenesis
11/18/10
Aromatase inhibitors have numerous side effects in addition to musculoskeletal symptoms
11/14/10
Blueberry compound pterostilbene increases effectiveness of tamoxifen
11/08/10
Response to neoadjuvant chemotherapy depends on dosage and tumor type
10/23/10
Asian-American women have higher rates of HER2-positive breast cancer than Caucasians
09/26/10
Radiotherapy for Hodgkin's lymphoma increases subsequent risk of breast cancer
09/12/10
Breast cancer prognosis - risk of locoregional recurrence by breast cancer subtype
09/09/10
Flaxseed enhances Herceptin treatment in mouse model of HER2 breast cancer
07/19/10
Women with high BMI may benefit less from hormonal treatments
07/16/10
The phytoestrogen quercetin does not protect against breast cancer and may promote it
06/28/10
Medications to avoid while on tamoxifen
06/03/10
Differences in hormone receptor status between primary breast tumor and mets is common
05/24/10
Prenatal exposure to BPA and DES increases subsequent risk of breast cancer
02/05/10
Vitamin D and calcium intakes influence risk of breast cancer
01/31/10
Migraine sufferers have lower risk of ER+/PR+ tumors - implications for choice of treatment
01/03/10
Black women less likely to survive ER+/PR+ breast cancer - what to do

Studies




Breast cancer resources | Definitions | Selected supplements and vitamins | Privacy policy | Search | Tags | Disclaimer/about us | Free newsletter/Donate | Sitemap